Medical Marijuana, Inc. Subsidiary HempMeds® Exhibits at The American Academy of Anti-Aging Medicine (A4M) World Conference

SAN DIEGO, Dec. 12, 2017 /PRNewswire/ — Medical Marijuana, Inc. (OTC:MJNA), the first publicly traded cannabis company in the U.S., announced today that subsidiary HempMeds® is exhibiting at The American Academy of Anti-Aging Medicine (A4M) 25th Annual World Conference which will take place in Las Vegas, NV on December 14-16, 2017.
This conference is organized annually to discuss traditional medical education and the advancements of preventative and anti-aging medicine. It hosts 3,000 to 5,000 physicians and healthcare practitioners and over 600 exhibitors from across the globe every year.
At booth #2073, HempMeds® representatives will be highlighting its groundbreaking Real Scientific Hemp Oil (RSHO) including its CBD hemp oil raw ingredient and zero-THC Real Scientific Hemp Oil-X (RSHO-X), the first-ever cannabis product to receive approval from the federal government of Mexico for importation. Additionally, they will be showcasing their Dixie Botanicals lifestyle supplement consumer-friendly products like stevia-sweetened hemp oil tinctures, vegan capsules, and a topical salve.
“We are proud to exhibit at this important event and speak with an international audience about our products and the benefits of CBD,” said Medical Marijuana, Inc. CEO Dr. Stuart Titus. “CBD has many health and wellness benefits that are currently being researched throughout the world for potential therapeutic efficacy.”
Those interested in learning more about HempMeds® and its products are encouraged to visit
About Medical Marijuana, Inc.
We are a company of firsts®. Our mission is to be the premier cannabis and hemp industry innovators, leveraging our team of professionals to source, evaluate and purchase value-added companies and products, while allowing them to keep their integrity and entrepreneurial spirit. We strive to create awareness within our industry, develop environmentally-friendly, economically sustainable businesses, while increasing shareholder value. For details on Medical Marijuana, Inc.’s portfolio and investment companies, visit
To see Medical Marijuana, Inc.’s corporate video, click here.
Shareholders are also encouraged to visit the Medical Marijuana, Inc. Shop for discounted products.
This press release may contain certain forward-looking statements and information, as defined within the meaning of Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934, and is subject to the Safe Harbor created by those sections. This material contains statements about expected future events and/or financial results that are forward-looking in nature and subject to risks and uncertainties. Such forward-looking statements by definition involve risks, uncertainties. The statements in this press release have not been evaluated by the FDA and are not intended to diagnose, treat or cure any disease.  The Company does not sell or distribute any products that are in violation of the United States Controlled Substances Act.  The Company does sell and distribute hemp-based products.
Public Relations Contact:
Andrew Hard
Chief Executive Officer
CMW Media
P. 888-829- 0070
The post Medical Marijuana, Inc. Subsidiary HempMeds® Exhibits at The American Academy of Anti-Aging Medicine (A4M) World Conference appeared first on Medical Marijuana, Inc. (OTC: MJNA).

Go to Source

Powered by WPeMatico